Matsuoka N, Aigner T G
Laboratory of Neuropsychology, National Institute of Mental Health, Bethesda, MD 20892, USA.
Neuroreport. 1996 Jan 31;7(2):565-8. doi: 10.1097/00001756-199601310-00045.
Administration of either a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 (dizocilpine), or a muscarinic antagonist, scopolamine, produces dose-related impairments in performance of a visual recognition memory task, delayed non-matching to sample (DNMS) with lists of 20 symbols, in rhesus monkeys. In the present study, low doses of these two drugs, which were ineffective when given alone, significantly impaired performance when given in combination. Moreover, the effect was greater than additive, indicating a synergistic interaction. These results suggest that interactions between cholinergic and glutamatergic systems play an important role in regulation of visual recognition memory.
给恒河猴施用非竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂MK-801(地佐环平)或毒蕈碱拮抗剂东莨菪碱,会使其在视觉识别记忆任务(即使用包含20个符号的列表进行延迟样本不匹配任务,DNMS)中的表现出现剂量相关的损伤。在本研究中,单独给药无效的这两种药物的低剂量联合给药时,显著损害了表现。此外,这种效应大于相加作用,表明存在协同相互作用。这些结果表明,胆碱能系统和谷氨酸能系统之间的相互作用在视觉识别记忆的调节中起重要作用。